Quest Diagnostics Incorporated AI Price Prediction

Based on the provided valuation metrics, Quest Diagnostics appears solidly profitable with a relatively low earnings multiple. A PE ratio of 12.23 on EPS of 15.07 implies the market is not aggressively pricing in growth despite strong current earnings power. This combination suggests the stock is reasonably valued to modestly undervalued relative to its earnings profile.

• EPS of 15.07 indicates strong absolute earnings power, supporting the current share price around $184.
• A PE ratio of 12.23 is on the low-to-mid side for a stable, cash-generative healthcare services company, suggesting the market is not overpaying for current earnings.
• The low multiple combined with solid EPS implies healthy profitability and potential upside if growth or sentiment improves.

Alternative data signals point to strong and engaged demand for Quest Diagnostics’ services. Very high web traffic and robust daily app downloads suggest healthy customer interaction and digital engagement, which are important for a consumer-facing diagnostics business. Social media and LinkedIn follower growth, especially on professional platforms, supports a positive brand and hiring/enterprise demand backdrop.

• Estimated 13.66 million monthly website visitors indicates substantial digital reach and ongoing customer engagement, supportive of stable or growing test volumes.
• Roughly 49,000 mobile app downloads per day is a very strong signal of user acquisition and digital channel adoption, which can enhance customer stickiness and operational efficiency.
• Social media presence is broad, with modest but generally positive follower growth across Instagram, Facebook, YouTube, TikTok, and especially LinkedIn (+1.1%), suggesting a healthy brand footprint and professional interest despite a slight decline on Twitter/X.